Tech transfer & manufacturing for scaling biotech

Translating a promising therapeutic platform into a reproducible, GMP-compliant manufacturing process requires rigorous coordination across development and production teams. This panel brings together experts to discuss how biotech organizations can strengthen their technology transfer frameworks, improve scalability, and maintain product quality during rapid growth. 

Key takeaways 

• Define the core elements of a robust tech transfer framework for advanced therapies 

• Identify common challenges in scaling cell and gene therapy manufacturing 

• Evaluate approaches to maintain process comparability and product quality at scale 

• Discuss models for partnering with contract development and manufacturing organizations (CDMOs) 

• Explore digital and data-driven tools that enhance manufacturing readiness